Patents · 2022 · pending
Treatment of SOS2 Related Diseases and Disorders
siRNA and antisense oligonucleotides targeting SOS2, a Ras/Rho guanine nucleotide exchange factor, for related conditions.
- Filings
- 2
- Status
- Pending
- First priority
- May 23, 2022
Patents · 2022 · pending
siRNA and antisense oligonucleotides targeting SOS2, a Ras/Rho guanine nucleotide exchange factor, for related conditions.